SEC Form 4 · accession 0001193805-16-003193
ADMA BIOLOGICS, INC. · ADMA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James Mond
Officer — CSO/CMO
Period of report
May 3, 2016
Accepted (ET)
May 5, 2016 · 7:27 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001368514
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.0001 par value per share | May 3, 2016 | P | 770 | $6.50 | A | 3,389 | D |
Table II — derivative securities
No Table II lines on this filing.